鸡突变型和未突变型Mx蛋白体外抗病毒活性研究

【目的】研究鸡Mx蛋白第631位氨基酸变异与抗病性的相关性。【方法】用已经构建成功的中国狼山鸡Mx蛋白基因突变型pcDNA3.0-MMx和未突变型pcDNA3.0-Mx真核表达载体分别转染鸡成纤维（CEF）细胞和鼠成纤维（NIH-3T3）细胞;利用RT-PCR检测突变型MMx基因和未突变型Mx基因的表达,微量细胞病变抑制法测定重组蛋白抗新城疫病毒（NDV）和水泡性口炎病毒（VSV）的效果。【结果】诱变鸡Mx基因的表达重组蛋白可保护CEF细胞在孵育48 h内免受NDV的感染;转染突变型pcDNA3.0-MMx真核表达载体的NIH-3T3细胞在孵育60 h内亦未受到VSV的浸染;而转染未突变型pcDNA3.0-Mx真核表达载体的CEF和NIH-3T3细胞在24 h内均发生了病变。【结论】体外重组突变的Mx蛋白在单细胞水平上具有延缓NDV和VSV感染的能力。     

Prokaryotic Expression and Immunogenicity Analysis of N Protein from Vesicular Stomatitis Virus

This study was aimed to clone and express the specific antigen nucleoprotein (N) of vesicular stomatitis virus (VSV), and then purify and analyze its immunogenicity. Based on published VSV genome N gene sequence in GenBank, two kinds of N genes of VSV with different serotypes were synthesized, respectively. After sequence analysis, one pair of specific primers was designed and synthesized, N gene fragment with about 1 300 bp length was amplified by PCR, and subcloned into pCold Ⅰ expression vector. The recombinant N protein was induced with IPTG and purified by Ni-NTA. The results of SDS-PAGE showed that the N gene was successfully expressed in E. coli and the molecular weight of protein was 50 ku; The results of Western blotting showed that this recombined protein specifically reacted with polyclonal antibody serum of VSV. The recombinant vector with VSV-IND and VSV-NJ were successfully constructed, and the N protein was solubly expressed in E. coli, and the purified protein demonstrated promising immunogenicity.     

水疱性口炎病毒糖蛋白基因的克隆和表达

对一株实验室保存多年的水疱性口炎病毒(VSV)的囊膜糖蛋白(VSV_G)基因进行了克隆和测序,并且构建了重组VSV_G真核系统表达载体。结果表明克隆的VSV_G基因全长1536个核苷酸(nt),其编码的G蛋白长为511个氨基酸(aa),氨基酸序列与20个Indiana血清型VSV毒株的同源性在95.4%左右(94.1%～98.0%)。种系发生树分析表明此病毒株属于水疱病毒属的VSV_Indiana血清型。经免疫荧光检测证明构建的重组VSV_G表达质粒pCIVG5和pCRVG6转染23T细胞后能够有效地转录和表达,这为进一步开发利用VSV_G奠定了基础。     

水泡性口炎病毒单克隆抗体的制备与鉴定

将水泡性口炎病毒（VSV）经差速离心和蔗糖密度梯度离心法进行纯化后,以纯化的VSV作为免疫原免疫8～10周龄雌性BALB/c小鼠,取其脾细胞与SP2/0骨髓瘤细胞进行融合,经间接ELISA方法筛选能稳定分泌抗VSV单克隆抗体的杂交瘤细胞株,并对制备出的抗VSV单抗的特异性、抗体亚类等生物学特性进行鉴定。结果显示,试验成功筛选出2株能稳定分泌抗VSV单克隆抗体的杂交瘤细胞株,分别命名为1A2、4C3。ELISA鉴定结果表明,2株单抗均能特异性地与VSV结合,而与口蹄疫病毒（FMDV）、猪水泡病病毒（SVDV）均不发生交叉反应;诱生小鼠腹水产生的抗体效价可达1∶25 600～1∶51 200。杂交瘤细胞染色体核型鉴定结果显示,杂交瘤细胞染色体数为95～105,均高于2个亲本细胞的染色体数目,说明这2株细胞是两者的杂交产物。抗体亚类鉴定结果显示,所获得2株单抗1A2、4C3均为IgG1。Western blot分析结果表明,1A2可识别VSV G蛋白。2株抗VSV单克隆抗体的成功制备将为VSV快速检测方法的建立以及检测试剂的研制等奠定基础。     

多重RT-PCR检测猪口蹄疫病毒、猪水泡病病毒和猪水疱性口炎病毒的研究

建立了一种同时检测猪口蹄疫病毒(FMDV)、猪水泡病病毒(SVDV)和猪水疱性口炎病毒(VSV)三种病原体的多重RT-PCR方法。参照文献报道的基因序列,设计合成了三对特异性引物;PCR扩增条件进行优化后,用这三对引物对同一样品中的FMDV、SVDV、VSVRNA模板进行扩增,结果同时得到了三条特异性条带,大小与试验设计相符:FMDV(208bp)、SVDV(862bp)、VSV(638bp),且对猪瘟病毒(CSFV)、猪繁殖与呼吸综合症病毒(PRRSV)和猪传染性胃肠炎病毒(TGEV)核酸扩增结果为阴性;三种病毒RNA模板检出的最小量均为10fg。试验证明,此方法经济、快速、敏感、特异,可用于FMDV、SVDV和VSV这三种猪水泡性疾病的鉴别诊断及流行病学调查。     

天府肉鹅IFN-α成熟肽基因的原核表达及抗病毒活性

参照已克隆的天府肉鹅IFN-α完整ORF基因序列设计引物,克隆成熟肽基因,与载体pET32a连接,构建原核表达载体,并在表达菌Rosetta中表达,SDS-PAGE分析鉴定,通过Ni-IMAC亲和层析纯化和稀释透析复性后,采用微量细胞病变抑制法分析测定IFN的抗病毒活性.结果显示,IFN-α成熟肽基因全长486 bp,...     

水泡性口炎病毒N蛋白原核表达及免疫原性分析

本研究旨在克隆和表达水泡性口炎病毒（vesicular stomatitis virus,VSV）特异性抗原N蛋白,进而纯化并分析其免疫原性。根据GenBank中已发表的VSV基因组N基因序列,分别合成VSV两种不同血清型的N基因,经序列对比分析后,设计合成1对特异性引物,PCR扩增获得约1 300 bp的N基因片段,将目的片段亚克隆至pCold Ⅰ原核表达载体中,经IPTG诱导表达后,采用Ni-NTA树脂亲和层析法纯化重组N蛋白。SDS-PAGE分析表明,N基因在大肠杆菌中得到表达,蛋白大小约为50 ku;Western blotting检测结果表明,该重组蛋白与VSV多克隆抗体发生特异性反应。本试验成功构建了VSV-IND和VSV-NJ的原核表达载体,实现了N蛋白在大肠杆菌中的可溶性表达,纯化后的重组蛋白具有良好的免疫原性。     

卡介菌多糖核酸体外抗病毒活性试验

为探讨卡介菌多糖核酸(BCG-PSN)的抗病毒效果,对离体培养的鸡胚成纤维(CEF)细胞进行水疱口炎病毒(VSV)感染,用四甲基偶氮唑盐(MTT)比色法检测BCG-PSN对CEF细胞活性的影响;用细胞病变法(CPE)检测BCG-PSN对VSV的抑制作用,并在安全浓度范围内筛选BCG-PSN抑制VSV的最佳作用时间和作用剂量。试验结果表明:BCG-PSN能显著抑制VSV在CEF细胞上的生长,但抑制作用并非随着其剂量的增加和作用时间的延长而增强,质量浓度为144.0μg/mL的BCG-PSN在CEF细胞上作用24 h后,产生的抗病毒活性最强;当BCG-PSN质量浓度大于800μg/mL时则对CEF细胞具有明显的毒性作用。BCG-PSN可诱导CEF细胞产生IFN-α和IFN-β,研究结果显示:BCG-PSN的抗病毒作用与其诱导的干扰素有关。     

Vesicular Stomatitis

Vesicular stomatitis is a disease of livestock caused by some members of the Vesiculovirus genus (Family Rhabdoviridae), two of which are called 'vesicular stomatitis virus'. Clinical disease presents as severe vesiculation and/or ulceration of the tongue, oral tissues, feet, and teats, and results in substantial loss of productivity. Except for its appearance in horses, it is clinically indistinguishable from foot-and-mouth disease. Unlike foot-and-mouth disease, it is very infectious for man and can cause a temporarily debilitating disease. Vesicular stomatitis occurs seasonally every year in the southeastern USA, southern Mexico, throughout Central America and in northern South America, and emerges from tropical areas to cause sporadic epidemics in cooler climates during the summer months. Other Vesiculoviruses are endemic in India and Africa. Vesiculoviruses are arthropod-borne and it is possible they are actually well adapted insect viruses that incidentally infect mammals.Vesiculoviruses are relatively simple, having a linear, single stranded, negative sense RNA genome encased in a bullet-shaped virion made from only five proteins. Upon infection of cultured cells, viral products turn off cellular gene expression and seize the entire metabolic potential of the cell. They also depolymerize the cytoskeleton to cause rapid tissue destruction. Virus infection in animals provokes interferon and nitric oxide responses, which quickly control viral replication, and an antibody response that prevents further viral replication.Vesiculovirus genome replication is error-prone, resulting in viral progeny containing many variants. This allows rapid adaptation. Nevertheless, vesicular stomatitis virus genomic sequences appear relatively stable within single endemic areas, and vary progressively on a North-South axis in the Western Hemisphere.Numerous important fundamental discoveries in immunology and virology have come from recent studies of vesicular stomatitis virus. However, these discoveries have not led to a safe and fully effective vaccine for man or beast. In the absence of a vaccine, the continual increase in rapid intercontinental travel, the increase in numbers and concentration of susceptible animals, the plasticity of the viral genome, and the underappreciation of vesiculoviruses as veterinary and zoonotic pathogens by regulators and biomedical researchers, are combining with potentially explosive consequences.     

Transient expression of an active human interferon-beta in lettuce

Using Agrobacterium mediated transient expression method, plant bivalent expression vector pBI121 containing GUS as a report gene was transformed into lettuce (Lactuca sativa). Through designed orthogonal analysis, intact lettuce leaves infiltrated with 200 μM acetosyringone and 0.8 OD₆₀₀ bacterial suspensions under vacuum for 30 min, then co-cultured at 24 °C for 6 ds produced a maximum GUS protein of 2.5% TSP with 21.39 nmol mg⁻¹ min⁻¹ MU activity, which was 19 times of the control (1.31 nmol mg⁻¹ min⁻¹ MU). Employed these optimized conditions HuIFN-beta was expressed in lettuce leaves. Western blot and antivirus bioactivity analyses confirmed the HuIFN-beta achieved by agrobacterium infiltration had a high biological activity (3.1 × 10⁴ IU/mL). To our knowledge, it is the first detailed orthogonal optimizing study of Agrobacterium mediated transient expression and the first report on the production of the biologically active therapeutic proteins produced by Agrobacterium mediated transient expression in lettuce. In summary, transient expression by Agrobacterium vacuum infiltration can be adopted as an efficient, inexpensive and small-scaled plant expression system for therapeutic protein production.